Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Philipp Schachtschneider"'
Autor:
Oliver Stoeltzing, Edward K. Geissler, Hans J. Schlitt, David Batt, Andreas Gaumann, Christina Hackl, Akira Mori, Christian Moser, Philipp Schachtschneider, Sven A. Lang
Supplementary Fig. S1 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72602e2e3037c0e98d118eddb7291119
https://doi.org/10.1158/1535-7163.22483097.v1
https://doi.org/10.1158/1535-7163.22483097.v1
Autor:
Oliver Stoeltzing, Edward K. Geissler, Hans J. Schlitt, David Batt, Andreas Gaumann, Christina Hackl, Akira Mori, Christian Moser, Philipp Schachtschneider, Sven A. Lang
Supplementary Fig. S3 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3847a0094ccb9cb5b31a8b0eea7c18a6
https://doi.org/10.1158/1535-7163.22483091.v1
https://doi.org/10.1158/1535-7163.22483091.v1
Autor:
Oliver Stoeltzing, Edward K. Geissler, Hans J. Schlitt, David Batt, Andreas Gaumann, Christina Hackl, Akira Mori, Christian Moser, Philipp Schachtschneider, Sven A. Lang
The Ras/Raf/MEK pathway represents an important oncogenic signaling pathway in gastrointestinal malignancies, including pancreatic cancer. Although activating B-Raf mutations are infrequent in pancreatic cancer, we hypothesized that targeting Raf cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107e50c1e4608618ad022f4a02cf96c1
https://doi.org/10.1158/1535-7163.c.6531068
https://doi.org/10.1158/1535-7163.c.6531068
Autor:
Oliver Stoeltzing, Edward K. Geissler, Hans J. Schlitt, David Batt, Andreas Gaumann, Christina Hackl, Akira Mori, Christian Moser, Philipp Schachtschneider, Sven A. Lang
Supplementary Fig. S2 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5a64e240da4cec7ab43020d93efd49
https://doi.org/10.1158/1535-7163.22483094
https://doi.org/10.1158/1535-7163.22483094
Autor:
Oliver Stoeltzing, Stefan Fichnter-Feigl, Hans J. Schlitt, Sven A. Lang, Philipp Schachtschneider, Volker Schmitz, Claus Hellerbrand, Edward K Geissler, Christian Moser
Publikováno v:
Hepatology (Baltimore, Md.). 49(2)
Hepatocellular carcinoma (HCC) remains associated with a poor prognosis, but novel targeted therapies in combination with anti-angiogenic substances may offer new perspectives. We hypothesized that simultaneous targeting of tumor cells, endothelial c
Autor:
Edward K. Geissler, Christian Moser, Hans J. Schlitt, Akira Mori, Philipp Schachtschneider, Christina Hackl, Sven A. Lang, Oliver Stoeltzing, David Bryant Batt, Andreas Gaumann
Publikováno v:
Molecular cancer therapeutics. 7(11)
The Ras/Raf/MEK pathway represents an important oncogenic signaling pathway in gastrointestinal malignancies, including pancreatic cancer. Although activating B-Raf mutations are infrequent in pancreatic cancer, we hypothesized that targeting Raf cou
Autor:
Hans J. Schlitt, Oliver Stoeltzing, Akira Mori, Sven A. Lang, Christian Moser, Edward K. Geissler, Philipp Schachtschneider, Andreas Gaumann, Johann Zimmermann
Publikováno v:
European journal of cancer (Oxford, England : 1990). 44(11)
The insulin-like growth factor-I receptor (IGF-IR) is frequently overexpressed and constitutively activated in pancreatic cancer, thus representing a promising target for therapy. We investigated the impact of a novel inhibitor of IGF-IR (NVP-AEW541)
Autor:
B. Kaufmann, Sa Lang, Philipp Schachtschneider, O. Stöltzing, C. Zülke, Christian Moser, HJ Schlitt, Edward K. Geissler
Publikováno v:
124. Kongress der Deutschen Gesellschaft für Chirurgie; 20070501-20070504; München; DOC07dgch7110 /20071001/
Chirurgisches Forum 2007 ISBN: 9783540711223
Chirurgisches Forum 2007 ISBN: 9783540711223
Overexpression of IGF-I/IGF-IR and activation of Ras/Raf signaling cascades have been implicated in angiogenesis and progression of human pancreatic cancer. Both signaling systems may up-regulate VEGF expression and mediate anti-apoptotic effects, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80bd9343637651c0bbcb0c770b28645e
http://www.egms.de/en/meetings/dgch2007/07dgch065.shtml
http://www.egms.de/en/meetings/dgch2007/07dgch065.shtml